feed,title,long_url,short_url
MarketWatch,Bristol Myers Squibb's Opdivo failed a study testing it as a treatment for rare cancer,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/0AKSeFZhIfU/story.aspx,https://on.mktw.net/2KSO7Nj
